By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
    Health
    Healthcare organizations are operating on slimmer profit margins than ever. One report in August showed that they are even lower than the beginning of the…
    Show More
    Top News
    HIPPA compliance
    How Medical Office Staff Can Make Your Practice HIPAA Compliant
    October 29, 2021
    Everything you need to know about hyaluronic acid treatment
    Everything you need to know about hyaluronic acid treatment
    February 10, 2022
    Which Mushroom Capsules Are Good for Your Health?
    May 5, 2022
    Latest News
    Why Custom Telemedicine Apps Outperform Off‑the‑Shelf Solutions
    July 20, 2025
    How Probate Planning Shapes the Future of Your Estate and Family Care
    July 17, 2025
    Beyond Nutrition: Everyday Foods That Support Whole-Body Health
    June 15, 2025
    The Wide-Ranging Benefits of Magnesium Supplements
    June 11, 2025
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
    Policy and Law
    Get the latest updates about Insurance policies and Laws in the Healthcare industry for different geographical locations.
    Show More
    Top News
    Image
    Healthcare Pricing Transparency Gains Momentum
    June 24, 2013
    non-clinical care factors in health outcomes
    Addressing Non-Clinical Care Factors in Health Outcomes
    November 15, 2013
    e interventions
    Healthcare Progress Depends On “E Interventions”
    July 10, 2014
    Latest News
    How IT and Marketing Teams Can Collaborate to Protect Patient Trust
    July 17, 2025
    How Health Choices and Legal Actions Intersect After an Injury
    July 17, 2025
    How communities and healthcare providers can address slip and fall injuries with legal awareness
    July 17, 2025
    Let Your Lawyer Handle the Work Before You Pay Medical Costs
    July 6, 2025
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Involving Pharma in Social Media: Chat 122 Summary
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > eHealth > Social Media > Involving Pharma in Social Media: Chat 122 Summary
eHealthSocial Media

Involving Pharma in Social Media: Chat 122 Summary

fannygillet
fannygillet
Share
6 Min Read
SHARE

On April 3rd, we explored as yet uncharted territory for #hcsmca, namely pharmaceutical companies, their reputation and the role they can or should play in the future of health care. The chat was moderated by @williampearl who also wrote an article on her blog, Social Media Pearls, introducing her framing of the topics.

On April 3rd, we explored as yet uncharted territory for #hcsmca, namely pharmaceutical companies, their reputation and the role they can or should play in the future of health care. The chat was moderated by @williampearl who also wrote an article on her blog, Social Media Pearls, introducing her framing of the topics.

T1: What can pharmaceutical companies do to improve their reputation /relationships in health care?

The first comments pointed to transparency and accountability as key ingredients to improving their reputation. They should, for example, explain where the money goes, why they stop certain drug production or how they target the research funds.

T1 They can ensure needed drugs don’t disappear unexpectedly or for no reason but $ #hcsmca

— Annette McKinnon (@anetto) 3 avril 2013

T1: Show they are invested in positive patient outcomes (not just $)e.g. compassionate use as mentioned by @cloudhealth #hcsmca

— Anne Dang, CCPA (@AnneCCPA) 3 avril 2013

Participants cited examples of positive actions that pharmaceutical companies have taken. @CLOUDHealth mentioned Pfizer’s role in a young boy’s recovery and @Colleen_Young linked to a now archived website – SharingStrength.ca – for women with breast cancer in Canada that was sponsored by Astra Zeneca. Others reminded us that some pharma companies help patients pay for their drugs and finance non-profit organizations.

More Read

health IT
When Health IT Is the Patient
The High Cost of Low Patient Satisfaction Scores [INFOGRAPHIC]
4 Common Myths About Online & Social Media Health Content Debunked
Patients Going Mobile: The Consumerization of Radiology
Are Digital Medical Records Harder to Protect?

When developing SharingStrength.ca sponsored by AstraZeneca, we held patient focus groups. Patients were positive abt pharma.#hcsmca

— Colleen Young (@colleen_young) 3 avril 2013

Hcsma-ers agreed that pharmaceutical companies have to be transparent when they sponsor organizations. When it is correctly managed, it seems that patients have no problem with the fact that a pharmaceutical company is involved.

@hhampson they were okay about pharma sponsoring patient education and online community with proper governance #hcsmca

— Colleen Young (@colleen_young) 3 avril 2013

Some hcsmca-ers think they also have to show transparency regarding their trials and notably the ones that are not made public. Besides, @rhartnup shared the website AllTrials.net that is petitioning to have all trials past and present registered, and the full methods and the results reported. They hope to encourage governments, regulators and research bodies to implement measures to achieve this.

@anetto There is a movement now led by @bengoldacre to address this, since trials with negative results are important to know about #hcsmca

— Ruth Hartnup (@rhartnup) 3 avril 2013

Hcsmca-ers also approached the subject of sponsored continuing medical education (CME). Indeed, pharmaceutical companies are very involved in funding CME. Some questioned the sustainability of CME without their financial help. However, in a perfect world, they should invest in CME without influencing the healthcare professionals on their prescription practice.

@stevedempsey Good question. More specifically, how willing is pharma to fund hands-off CME with no product references? #hcsmca

— Pat Rich (@cmaer) 3 avril 2013

Docs should learn to critically appraise any research/advice given to them by pharma so as to make their own judgement #hcsmca

— Sunny Chan (@waisunchan) 3 avril 2013

T2: How can pharmaceutical companies help/support the social change in health care and patient communities?

Hcmaca-ers mentioned that these companies should listen more to what’s happening on social media and to the patient’s voice. However it was noted that because of legislation regulating pharma, they don’t have a big field of action.

T2: Informing and engaging important stakeholders in social media, dialogue in tweetchats (HCP or pt-oriented) is a good start #hcsmca

— Anne Dang, CCPA (@AnneCCPA) 3 avril 2013

It is difficult not to be suspicious when it comes to pharmaceutical companies actions. Hcsmca-ers tend to think that whatever they do, there is a marketing goal behind their action. They are a business and like all businesses they need to see a return on investment.

Also need to remember pharma are very profitable businesses so they need an ROI to contribute even if just altruisim = more goodwill #hcsmca

— Pat Rich (@cmaer) 3 avril 2013

During this chat @willimapearl also mentioned the new titles that she observed appearing in pharmaceutical companies, such as “Director of Patient Experience” or “Director of Patient Advocacy”.

@williampearl Yes – again, part of pharma marketing strategies. Not altruism – just good business #hcsmca

— Carolyn Thomas (@HeartSisters) 3 avril 2013

Community members also think pharma could help patients find treatment alternatives to manage their diseases.

T1:Rx co’s “could” also invest in developing alt solns to “prescriptions” by adding grt research approaches to natural alternatives #hcsmca

— PaulGallant CHE MHK (@HealthWorksBC) 3 avril 2013

If I could sum up this discussion with one word, that would be scepticism. Indeed, even if we saw some examples of positive actions, pharmaceutical companies’ good will remains in doubt. When talking about pharmaceutical companies, nothing is simply black or white. They have a big role to play in patients’ lives but they also have to be disassociated.

Can it be that pharma has such a stinky rep that even being transparent will be suspicious? #hcsmca

— kathy kastner (@KathyKastner) 3 avril 2013

The full transcript is well worth the read.

Edited by Colleen Young

TAGGED:chatHCSMCAhealthcare social mediapharma
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

botox certification
Help Improve People’s Skin Health Via Botox Certification
Skin Specialties
July 22, 2025
Telemedicine Apps
Why Custom Telemedicine Apps Outperform Off‑the‑Shelf Solutions
Health
July 20, 2025
Grounded Healing: A Natural Ally for Sustainable Healthcare Systems
How IT and Marketing Teams Can Collaborate to Protect Patient Trust
Global Healthcare Policy & Law
July 17, 2025
paramedics in surgical gloves and masks
How Health Choices and Legal Actions Intersect After an Injury
Health care
July 16, 2025

You Might also Like

EMR and meaningful use
eHealthHealth ReformMedical RecordsPolicy & Law

The Tyranny of Electronic Systems

October 24, 2013
eHealthGlobal HealthcarePolicy & LawTechnology

Predictive Analytics and Data Mining Reduce Healthcare Costs and Improve Outcomes

October 16, 2017

What Healthcare Can Learn From the New Department of Defense (DoD) Mobility Device Strategy

June 18, 2012
eHealthMedical Records

Why Cybersecurity Should Be Healthcare’s Number One Priority

April 3, 2018
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?